Over 10p today :) |
lol I bought more here today ;) |
Pull back and ready to take back off again ;) |
Nearly 200% from some of my low purchases :):):):):) still more to come here today and certainly next week ;) |
£18.38K delayed buy from earlier just showing, whoever it was paid premium for them, looking good here. |
When the 🤡 over on LSE are posting so many positives about this you really know you're on to a good thing. |
£14 million market cap,and the potential to get into the hundreds of millions,buy and hold,you will not be disappointed. |
Nice little RNS,every positive one helps,SP here is a ticking time bomb, 💣 soon. |
Nice little top up opportunity :) |
Been buying since December ;) |
🚀🚀🚀🚀8640;🚀Ԇ40;🚀🚀;🚀 SOON! |
FDA news will rocket the SP, loading up more tomorrow if we don't get the RNS first thing. |
Been buying here since December... FDA 510k submission for CARDIO inCode news expected any time in the next few weeks. |
Where is everyone ?? |
£4 million placing end of December,that along with company revenue should last minimum of 6 months,so hopefully no raise needed until after June when i believe the share price will be way higher than of today,so tomorrow i will be loading up more funds here, what with expected news flow over coming months i see this as a no lose play, that is until probably a fundraiser in the summer. |
This and GENF are probably two of the most undervalued pharma companies around. |
Well i would say that the USA FDA news,which is due very soon, will undoubtedly be passed,this little gem could be valued in the £100's of million's in a few years,buy now and come back next year,i guarantee you won't be disappointed. |
The news today regarding NICE endorsment for the ROCA test was welcome and must bode well for approval and reimbursment in other Jurisdictions |
Yes, Investors are currently in a mind set that persuades them the next fund raise will inevitably be at lower price than the last one, irrespective of progress made by the company in question. This will revert back to the more normal paradigm (eventually) whereby successive fund raisings are conducted at higher prices to reflect positive progress, but alas, I cannot see that happening in the short term. |
I picked up a few GENI shares in the placing, it was EIS qualifying, so the up front tax relief means an effective purchase price of 3.5p/share for UK tax payers (like myself)
The blurb which came round with the placing documentation stated they were looking to raise £5m in the firm placing, plus anything extra in the retail offer. The initial indicative price was 5p/share and that didn't shift throughout the 5 day period between when I was made inside and when they announced the placing. |
In September Interims Presentation (link below) management said they will need to raise £8m.
The December fundraise was for only £4m.
Consequently, whilst any good news may temporarily spike the share price, the knowledge that another £4m is needed will - in my view - temper it.
hxxps://youtu.be/pLNE8uKfUgc?si=H2DLZozBw5iQurmf&t=2194 |
This is going to explode soon, definitely 😁 |
5p - will probably double my existing holding without much enthusiasm |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
